Analyst
MST Marquee
Dan Hurren
Healthcare Analyst
Request Access
About
Dan joined MST Marquee in 2021 to partner with senior healthcare analyst Andrew Goodsall. Dan and Andrew were the #1 ranked healthcare research team from 2004 to 2014 at Citi and UBS. Dan moved to Singapore in 2014 where he was head of the UBS Australian Sales Desk for six years. Before his equities career, Dan spent 15 years as an Australian Regular Army Officer serving in Australia and offshore. Dan has a Bachelor of Arts from the University of New South Wales and a Masters of International Studies from Sydney University. Dan Hurren is a representative of Health Finance Group Pty Ltd, who is an authorised representative of MST Financial.
Stock Coverage
Resmed Inc
RMD.AX
Integral Diagnostics Limited
IDX.AX
Neuren Pharmaceuticals Limited
NEU.AX
Sigma Healthcare Limited
SIG.AX
Capitol Health Ltd
CAJ.AX
Ansell Ltd
ANN.AX
EBOS Group Ltd
EBO.AX
Fisher & Paykel Healthcare Corporation Ltd
FPH.AX
Medical Developments International Limited
MVP.AX
Opthea Limited
OPT.AX
Oneview Healthcare PLC
ONE.AX
Alterity Therapeutics Limited
ATH.AX
Request Access
Unlock comprehensive
analyst research and insights.
Already have an account? Log in
All material on this website has been prepared by MST Financial Services Pty Limited (ABN 54 617 475 180, AFSL 500 557) for general informational purposes only and is not a solicitation of any offer to buy or sell any financial instrument or to participate in any trading strategy. Unless otherwise stated, the material presented on this site is not a research report as defined under ASIC guidance. For wholesale clients only. This material is only prepared for wholesale clients pursuant to section 761G(7) of the Corporations Act (Commonwealth). Please also refer to MST's Privacy Policy which can be viewed here. Terms of Use can be viewed here.
© 2024 MST Financial | All rights reserved